National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)
R01AI081914
United States
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)
U19AI109945
United States
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)
U19AI109664
United States
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)
U19AI109664
United States
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)
HHSN272201200026C
United States
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)
P41GM103832
United States
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)
P50GM1003297
United States
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)
R01AI059536
United States
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)
R01AI077519
United States
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)
R01AI107056
United States
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)
R01GM053163
United States
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)
P41GM103399
United States
Department of Energy (DOE, United States)
DE-AC02-06CH11357
United States
Defense Threat Reduction Agency (DTRA)
DTRA 1_21_1_0002
United States
Defense Threat Reduction Agency (DTRA)
HDTRA1_12_1_0051
United States
Defense Threat Reduction Agency (DTRA)
HDTRA1_14_1_0013
United States
Citation
Journal: Cell Rep / Year: 2015 Title: An Intrinsically Disordered Peptide from Ebola Virus VP35 Controls Viral RNA Synthesis by Modulating Nucleoprotein-RNA Interactions. Authors: Daisy W Leung / Dominika Borek / Priya Luthra / Jennifer M Binning / Manu Anantpadma / Gai Liu / Ian B Harvey / Zhaoming Su / Ariel Endlich-Frazier / Juanli Pan / Reed S Shabman / Wah Chiu / ...Authors: Daisy W Leung / Dominika Borek / Priya Luthra / Jennifer M Binning / Manu Anantpadma / Gai Liu / Ian B Harvey / Zhaoming Su / Ariel Endlich-Frazier / Juanli Pan / Reed S Shabman / Wah Chiu / Robert A Davey / Zbyszek Otwinowski / Christopher F Basler / Gaya K Amarasinghe / Abstract: During viral RNA synthesis, Ebola virus (EBOV) nucleoprotein (NP) alternates between an RNA-template-bound form and a template-free form to provide the viral polymerase access to the RNA template. In ...During viral RNA synthesis, Ebola virus (EBOV) nucleoprotein (NP) alternates between an RNA-template-bound form and a template-free form to provide the viral polymerase access to the RNA template. In addition, newly synthesized NP must be prevented from indiscriminately binding to noncognate RNAs. Here, we investigate the molecular bases for these critical processes. We identify an intrinsically disordered peptide derived from EBOV VP35 (NPBP, residues 20-48) that binds NP with high affinity and specificity, inhibits NP oligomerization, and releases RNA from NP-RNA complexes in vitro. The structure of the NPBP/ΔNPNTD complex, solved to 3.7 Å resolution, reveals how NPBP peptide occludes a large surface area that is important for NP-NP and NP-RNA interactions and for viral RNA synthesis. Together, our results identify a highly conserved viral interface that is important for EBOV replication and can be targeted for therapeutic development.